Latest Breaking News On - Portfolio cash flow - Page 1 : comparemela.com

HarbourVest Global Private Equity : Annual Report – Year Ended 31 January 2024

One share. A world of private company opportunities. Annual Report and Accounts 12 Months to 31 January.

City ofUnited kingdomRichard hickmanLed warnerHarbourvest global private equity limitedRemuneration committeeCompany is harbourvest advisersNomination committeeService provider committeeRisk committeeLondon stock exchangeInvestment management committeeHarbourvest partnersInvestment committeeInformation committeeInvestment manager

HarbourVest Global Private Equity : Annual Report and Accounts for the 12 Months to 31 January 2024

One share. A world of private company opportunities. Annual Report and Accounts 12 Months to 31 January.

City ofUnited kingdomLed warnerRichard hickmanNomination committeeInvestment management committeeRisk committeeHarbourvest partnersInvestment committeeHarbourvest global private equity limitedService provider committeeRemuneration committeeLondon stock exchangeCompany is harbourvest advisersInformation committeeInvestment manager

Royalty Pharma : Q1 2024 Press Release - MarketScreener

Royalty Pharma : Q1 2024 Press Release - MarketScreener
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesRoche evrysdiPablo legorretaCabometyx cometriqTremfya crohnJohnson imbruvicaEmalex biosciencesNovarti promactaJohnson tremfyaAstellas pharmaBristol myersEuropean commissionEuropean medicines agencyTeva pharmaceuticalsExchange commissionBristol myers squibb

Royalty Pharma Reports First Quarter 2024 Results - Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma Reports First Quarter 2024 Results - Royalty Pharma (NASDAQ:RPRX)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesJohnson tremfyaEmalex biosciencesNovarti promactaTremfya crohnRoche evrysdiPablo legorretaJohnson imbruvicaExchange commissionPortfolio receiptsRoyalty pharmaChief executiveRoyalty receiptsPortfolio cash flowCash flowCapital deployment

Royalty Pharma Reports Q4 and Full Year 2023 Results

Royalty Pharma Reports Q4 and Full Year 2023 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEmalex biosciencesFarxiga onglyzaCabometyx cometriqRoche evrysdiPablo legorretaJohnson imbruvicaJohnson tremfyaAscendis pharmaNovarti promactaDrug administrationEuropean commissionTeva pharmaceuticals industries ltdTherapeutics incBristol myers squibbExchange commission